2026-04-14T08:00:38Zhttps://recercat.cat/oai/requestoai:recercat.cat:2445/1253592025-12-05T12:17:25Zcom_2072_1057col_2072_478916col_2072_478917
urn:hdl:2445/125359
Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer
Lesseur, Corina
Diergaarde, Brenda
Olshan, Andrew F.
Wünsch-Filho, Victor
Ness, Andrew R.
Liu, Geoffrey
Lacko, Martin
Eluf Neto, José
Franceschi, Silvia
Lagiou, Pagona
MacFarlane, Gary J.
Richiardi, Lorenzo
Boccia, Stefania
Polesel, Jerry
Kjaerheim, Kristina
Zaridze, David
Johansson, Mattias
Menezes, Ana A.
Curado, Maria Paula
Robinson, Max
Ahrens, Wolfgang
Canova, Cristina
Znaor, Ariana
Castellsagué, Xavier
Conway, David I.
Holcátová, Ivana
Mates, Dana
Vidensky, Marta
Healy, Claire M.
Szeszenia-Dabrowska, Neonila
Fabianova, Eleonora
Lissowska, Jolanta
Grandis, Jennifer R.
Weissler, Mark C.
Tajara, Eloiza H.
Nunes, Fabio D.
Carvalho, Marcos B. de
Thomas, Steve
Hung, Rayjean J.
Peters, Wilbert H. M.
Herrero, Rolando
Cadoni, Gabriella
Bueno de Mesquita, H. Bas
Steffen, Annika
Agudo, Antonio
Shangina, Oxana
Xiao, Xiangjun
Gaborieau, Valérie
Chabrier, Amélie
Anantharaman, Devasena
Boffetta, Paolo
Amos, Christopher I.
McKay, James D.
Brennan, Paul
Càncer de boca
Papil·lomavirus
Oral cancer
Papillomaviruses
We conducted a genome-wide association study of oral cavity and pharyngeal cancer in 6,034 cases and 6,585 controls from Europe, North America and South America. We detected eight significantly associated loci (P < 5 x 10(-8)), seven of which are new for these cancer sites. Oral and pharyngeal cancers combined were associated with loci at 6p21.32 (rs3828805, HLA-DQB1), 10q26.13 (rs201982221, LHPP) and 11p15.4 (rs1453414, OR52N2-TRIM5). Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L). Oropharyngeal cancer associations were limited to the human leukocyte antigen (HLA) region, and classical HLA allele imputation showed a protective association with the class II haplotype HLA-DRB1*1301-HLA-DQA1*0103-HLA-DQB1*0603 (odds ratio (OR) = 0.59, P = 2.7 x 10(-9)). Stratified analyses on a subgroup of oropharyngeal cases with information available on human papillomavirus (HPV) status indicated that this association was considerably stronger in HPV-positive (OR = 0.23, P = 1.6 x 10(-6)) than in HPV-negative (OR = 0.75, P = 0.16) cancers.
2018-10-16T13:04:47Z
2018-10-16T13:04:47Z
2016-12-01
2018-07-24T12:15:18Z
info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
Versió postprint del document publicat a: https://doi.org/10.1038/ng.3685
Nature Genetics, 2016, vol. 48, num. 12, p. 1544-1550
https://doi.org/10.1038/ng.3685
cc-by-nc-sa (c) Lesseur et al., 2016
http://creativecommons.org/licenses/by-nc-sa/3.0/es/
info:eu-repo/semantics/openAccess
Nature Publishing Group
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))